Palvella Therapeutics


Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.

Employees

11-50

Links


Org chart

Wes Kaupinen
President & CEO
Collapse
Braham Shroot
Chief Scientific Officer
Jeff Martini
Chief Scientific Officer
Kathy Goin
Chief Operating Officer
Matthew Korenberg
Chief Financial Officer
Christine Kampf
Vice President, Regulatory Affairs
Ashley Kline
Chief Commercial Officer (cco)

Board & advisors